OhMyV GmbH published the first taboo investor insights report by Tabu Ventures.
Public source
Publisher name
Public post
The first taboo investor insights report by Tabu Ventures has just been published. A must-read for what it takes to build and invest in taboo spaces. It's such an import…
Company
OhMyV GmbH
your health comes first
- Industry
- Biotechnology Research
- Location
- Berlin, DE
- Company size
- 2–10 employees
About OhMyV GmbH
In 2022, a cervical cancer scare transformed Katie Payne's life and sparked a mission to revolutionise sexual wellness. Katie’s personal experience revealed a critical gap in the sexual wellness market: the absence of products that truly prioritise vulva health while offering comprehensive protection against sexually transmitted infections (STIs). This lead to the creation of OhMyV - and the first consumer brand vögeln™ Our mission is to drive scientific innovation in sexual wellness, ensuring our products are inclusive, effective, and tailored to diverse needs while maintaining unwavering commitment to health and sustainability.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Tabu Ventures
Tabu Ventures published the first edition of the Taboo Investor Insights Report, covering topics such as why
Research & Knowledge
BioM Biotech Cluster Development GmbH
BioM Biotech Cluster Development GmbH published the 2025/26 Biotech Report titled BIOTECH IN BAVARIA - WHERE CHAMPIONS GROW.
Research & Knowledge
Culture Biosciences
Culture Biosciences published a new white paper titled Accelerate Bioprocess Development with Culture Console.
Research & Knowledge
endogene.bio
endogene.bio announced that the ERC project is going to rock.
Research & Knowledge
NetZeroNitrogen